Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT00512590 Completed - Pain Clinical Trials

Pilot Study: Relaxation and Guided Imagery in Hispanic Persons Diagnosed With Fibromyalgia

Start date: April 2005
Phase: N/A
Study type: Interventional

The purpose of this pilot study was to test the effects of a 10-week relaxation and guided imagery intervention on pain perception, functional status, self-efficacy and levels of distress in Hispanic adults diagnosed with fibromyalgia.

NCT ID: NCT00512395 Completed - Pain Clinical Trials

Influence of Epidural Analgesia in Elective Laparoscopic Colorectal Resections

Start date: November 2004
Phase: Phase 4
Study type: Interventional

Epidural anaesthesia in open surgery is a effective method for analgesia and has a positive effect on postoperative resolution of ileus. In laparoscopic surgery, the role of epidural surgery is not established. This prospective observational trial evaluates the effect of epidural analgesia in patients undergoing elective, laparoscopic colorectal surgery.

NCT ID: NCT00505362 Completed - Pain Clinical Trials

Pain Study of Rectus Muscle Closure at Cesarean Delivery

Start date: June 2006
Phase: N/A
Study type: Interventional

Suture reapproximation of the rectus muscles at primary cesarean delivery is a common practice about which there are no data. Some Obstetricians believe that suture reapproximation of the rectus muscles increases post-operative pain, and it may decrease adhesions, yet there are no published data to support or refute these claims. The purpose of this study is to assess the effect of rectus muscle reapproximation at cesarean delivery and post-operative pain. We also plan to assess the impact of rectus muscle closure on adhesions as seen at repeat cesarean delivery.

NCT ID: NCT00503984 Completed - Prostate Cancer Clinical Trials

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Start date: May 2007
Phase: Phase 1/Phase 2
Study type: Interventional

Azacitidine can reverse clinical resistance to docetaxel through upregulation of Growth Arrest and DNA Damage inducible alpha (GADD45α) and other epigenetically regulated genes.

NCT ID: NCT00500942 Completed - Pain Clinical Trials

Pain Quantification and Pain Management in Interventional Radiology (IR)

Start date: January 2003
Phase: N/A
Study type: Observational

Primary Objectives: - To measure and record patients' pain levels before, during, and after standard procedures performed in IR. - To compare different procedures to respective pain levels and patient satisfaction (as determined by questionnaire).

NCT ID: NCT00497276 Completed - Pain Clinical Trials

Comparison of Ultrasound and Nerve Stimulation Technique for Continuous Sciatic Nerve Block

Start date: August 2007
Phase: N/A
Study type: Interventional

The most useful method to manage pain after major foot and ankle surgery is infusion of local anesthetic with a catheter close to the sciatic nerve in the popliteal space above the knee joint. Inaccurate catheter placement and spread of local anesthetic account for most failures. The most prevalent method to place the catheter is the traditional nerve stimulation technique relying on surface anatomic landmarks and electrical stimulation to localize the sciatic nerve. In recent years ultrasound technique has been applied to provide real-time, visual guidance of catheter placement. The purpose of this randomized, controlled trial is to compare the success rate, patient acceptance and cost-effectiveness of the ultrasound and nerve stimulation techniques.

NCT ID: NCT00496392 Completed - Pain Clinical Trials

Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)

Start date: January 2007
Phase: Phase 3
Study type: Interventional

Primary: • To compare the efficacy of nasal fentanyl (NF) to oral transmucosal fentanyl (Actiq®) (hereafter Actiq) in the management of breakthrough pain in cancer patients. Secondary: - To compare patients' general impression and preference of NF and Actiq - To explore the relationship between NF doses and dose of current opioid for breakthrough pain (BTP) and the relationship between dose of NF and of background opioid - To assess safety and tolerability of NF

NCT ID: NCT00493246 Completed - Pain Clinical Trials

Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric Inpatients

Start date: June 2007
Phase: Phase 1
Study type: Interventional

We are doing this study to find out what happens to acetaminophen in the body after it is given to children through the vein. Children's bodies may handle drugs differently than adults. Understanding how long the drug stays in the body and how the drug is changed or metabolized by the body (called pharmacokinetics) is an important step in learning what the best dose of acetaminophen for children should be. We are also interested in learning about the safety of this medication when given to children.

NCT ID: NCT00489684 Completed - Pain Clinical Trials

Effect of Opioids on Experimental Hyperalgesia in Oesophagus, Skin and Muscles

AEO-2007-01
Start date: August 2007
Phase: N/A
Study type: Observational

The study is a multi-modal multi-tissue human experimental pain study in 24 healthy volunteers. The study is a randomized cross-over study. The effect of 2 opioids will be compared on pain stimuli in skin, muscle an oesophagus. Hyperalgesia will be induced in skin and oesophagus, to sensitize these tissues. The pain thresholds before and after opioid administration will be compared. The hypothesis is that the difference in effect of the opioids is more pronounced in the presence of hyperalgesia. As hyperalgesia is a common phenomenon the clinic, the findings in this study may lead to a better understanding of the treatment of pain. The study will include an explorative study of the effect of Morphine of pain processing in the brain, this will provide us with new insight in the effect of the opioids of pain processing in the brain.

NCT ID: NCT00489411 Completed - Pain Clinical Trials

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Start date: April 2008
Phase: Phase 3
Study type: Interventional

RATIONALE: Duloxetine may lessen peripheral neuropathy caused by chemotherapy. It is not yet known whether duloxetine is more effective than a placebo in treating peripheral neuropathy caused by chemotherapy. PURPOSE: This randomized phase III trial is studying duloxetine to see how well it works compared with a placebo in treating peripheral neuropathy caused by chemotherapy in patients with cancer.